Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials

BACKGROUND: Bempedoic acid is a new drug that reduces cholesterol synthesis via inhibiting ATP citrate lyase. It remains unclear whether the combination of bempedoic acid and other lipid-lowering drugs is better than these drugs alone. This study systematically reviewed the efficacy and safety of be...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiang, Ma, Xubiao, Luo, Xing, Shi, Zhihua, Deng, Ziwen, Jin, Yuanxiang, Xiao, Zhipeng, Tan, Liming, Liu, Pingfang, Jiang, Shilong, Shu, Yuanglu, Tang, Bing, Qiu, Chengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716459/
https://www.ncbi.nlm.nih.gov/pubmed/33276805
http://dx.doi.org/10.1186/s40360-020-00463-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716459/
https://www.ncbi.nlm.nih.gov/pubmed/33276805
http://dx.doi.org/10.1186/s40360-020-00463-w

Ejemplares similares